GSK plc - Significant Ownership

Signature - Title
Gsk Plc - Victoria A. Whyte / Authorized Signatory
Location
London, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GSK plc.

Significant Ownership of GSK plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRO SPERO THERAPEUTICS, INC. Common Stock, Par Value $0.001 16.4% $6.8M 9.19M GSK PLC Mar 27, 2025

Schedules 13D/G Reported by GSK plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.